Evidation Health

Executive Summary

Evidation Health is a pioneering digital health company that aggregates and analyzes multimodal real-world health data from a large, consented patient population. By directly engaging individuals, Evidation enables life sciences and healthcare organizations to conduct faster, evidence-based research and decisions. The company's platform offers continuous, real-time data access, empowering patients to benefit from their own information while facilitating recontactable cohorts for clinical studies. Founded in 2012 and headquartered in San Mateo, California, Evidation focuses on leveraging AI and machine learning to derive insights from diverse data sources, including wearables, electronic health records, and patient-reported outcomes. With the growing emphasis on decentralized clinical trials and real-world evidence, Evidation is well-positioned to capitalize on the shift toward patient-centric, data-driven healthcare. The company's value proposition lies in its ability to accelerate research timelines, reduce costs, and improve outcomes by providing rich, longitudinal data that traditional methods cannot capture. While Evidation operates in a competitive landscape with players like DarioHealth and Hu-manity.co, its established platform and partnerships with top pharmaceutical companies provide a strong foundation for growth. The organization's focus on ethical data use and patient empowerment aligns with regulatory trends favoring transparency and consent. As the demand for real-world evidence continues to rise, Evidation is poised to play a critical role in shaping the future of clinical research and personalized medicine.

Upcoming Catalysts (preview)

• Q4 2026Major pharmaceutical partnership for decentralized clinical trial70% success
• Q2 2027FDA clearance or breakthrough device designation for AI-driven analytics platform50% success
• Q1 2027Expansion of patient network to include new therapeutic areas80% success